pharmaphorum
DECEMBER 14, 2022
In order to bring it to market, a special program called Risk Evaluation and Mitigation Strategy (REMS) had to be put in place, where only eligible patients could access the drug through a very strict process. Furthermore, Molina stated Jazz “suppressed generic competition and raised the price of Xyrem 841% between 2007 and 2014.”
Clarity Engagement Solutions
NOVEMBER 9, 2020
These awards can include holidays, educational support, providing a company dinner or invitations to special company events. Non-financial recognition: These types of rewards cover a wide range of additional benefits that vary in cost depending on the specific award.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Clarity Engagement Solutions
NOVEMBER 9, 2020
These awards can include holidays, educational support, providing a company dinner or invitations to special company events. Non-financial recognition: These types of rewards cover a wide range of additional benefits that vary in cost depending on the specific award.
PM360
JUNE 16, 2023
In 2007, Alexion set a new pricing milestone of $500,000 annually for Soliris , a treatment for an ultra-rare blood disorder. Managing the complexity of commercializing rare and orphan therapies requires specialized Marketing, Medical Affairs, and Market Access teams that are up to the task. References: 1. Pharmacoeconomics.
CloserIQ
OCTOBER 10, 2018
Founded 2007. Founded 2007. Founded 2007. BondLink is a fintech company specializing in the municipal bond market. Founded 2007. Formlabs is hiring sales professionals across all levels of expertise. The company has been noted for a fun, relaxed workplace culture that enables autonomy. 3Play Media. See open roles.
Evolve Your Success
FEBRUARY 21, 2023
In this episode, Samuel Adeyinka interviews special guests Chandler Holderness and Evan Gorges to share their fascinating journey and top shelf performances on the road to disrupting industries. Chandler and Evan are both part-owners of a medical device distributorship specializing in spine, and part-owners of a surgeon branding company.
pharmaphorum
NOVEMBER 30, 2022
The question is, how can the journey there be accelerated, when on the horizon awaits a life sciences future very much immersed in speciality medicine? Founded in 2007 by Peter Gassner, a luminary of Silicon Valley with a net worth of circa $5.25 A 10th anniversary reconnection, reassessment, and race for relevance.
Expert insights. Personalized for you.
116 
Let's personalize your content